This paper is available on arxiv under CC 4.0 license.
Authors:
(1) Matu´s Medo, Department for BioMedical Research, Inselspital, Bern University Hospital, University of Bern, Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern and [email protected];
(2) Michaela Medova, Department for BioMedical Research, Inselspital, Bern University Hospital, University of Bern, and Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern.
We thank Charlotte Ng and Peter Degen for their useful feedback.
Alexandrov, L.B., Kim, J., Haradhvala, N.J., Huang, M.N., Tian Ng, A.W., Wu, Y., Boot, A., Covington, K.R., Gordenin, D.A., Bergstrom, E.N., et al., 2020. The repertoire of mutational signatures in human cancer. Nature 578, 94–101.
Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A., Behjati, S., Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Børresen-Dale, A.L., et al., 2013. Signatures of mutational processes in human cancer. Nature 500, 415–421.
Berger, B., Yu, Y.W., 2022. Navigating bottlenecks and trade-offs in genomic data analysis. Nature Reviews Genetics , 1–16. Blokzijl, F., Janssen, R., van Boxtel, R., Cuppen, E., 2018. MutationalPatterns: Comprehensive genome-wide analysis of mutational processes. Genome Medicine 10, 1–11.
Brady, S.W., Gout, A.M., Zhang, J., 2022. Therapeutic and prognostic insights from the analysis of cancer mutational signatures. Trends in Genetics 38, 194–208.
Cannataro, V.L., Mandell, J.D., Townsend, J.P., 2022. Attribution of cancer origins to endogenous, exogenous, and preventable mutational processes. Molecular Biology and Evolution 39, msac084.
Degasperi, A., Zou, X., Dias Amarante, T., Martinez-Martinez, A., Koh, G.C.C., Dias, J.M., Heskin, L., Chmelova, L., Rinaldi, G., Wang, V.Y.W., et al., 2022. Substitution mutational signatures in whole-genome–sequenced cancers in the UK population. Science 376, abl9283.
Diaz-Gay, M., Vangara, R., Barnes, M., Wang, X., Islam, S.A., Vermes, I., Narasimman, N.B., Yang, T., Jiang, Z., Moody, S., et al., 2023. Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment. bioRxiv , 548264doi:10. 1101/2023.07.10.548264. bioRxiv 2023.07.10.548264.
Gori, K., Baez-Ortega, A., 2020. sigfit: Flexible Bayesian inference of mutational signatures. bioRxiv , 372896doi:10.1101/372896. bioRxiv, 372896.
Gulhan, D.C., Lee, J.J.K., Melloni, G.E., Cortes-Ciriano, I., Park, P.J., 2019. Detecting the mutational signature of homologous recombination deficiency in clinical samples. Nature Genetics 51, 912–919.
Hubschmann, D., Jopp-Saile, L., Andresen, C., Kr ¨ amer, S., Gu, Z., Heilig, C.E., Kreutzfeldt, S., Teleanu, V., Fr ¨ ohling, S., Eils, R., et al., 2021. ¨ Analysis of mutational signatures with yet another package for signature analysis. Genes, Chromosomes and Cancer 60, 314–331.
Islam, S.A., D´ıaz-Gay, M., Wu, Y., Barnes, M., Vangara, R., Bergstrom, E.N., He, Y., Vella, M., Wang, J., Teague, J.W., et al., 2022. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genomics 2, 100179.
Kim, Y.A., Leiserson, M.D., Moorjani, P., Sharan, R., Wojtowicz, D., Przytycka, T.M., 2021. Mutational signatures: From methods to mechanisms. Annual Review of Biomedical Data Science 4, 189–206.
Koh, G., Degasperi, A., Zou, X., Momen, S., Nik-Zainal, S., 2021. Mutational signatures: Emerging concepts, caveats and clinical applications. Nature Reviews Cancer 21, 619–637.
Li, S., 2020. sigLASSO: Optimizing cancer mutation signatures jointly with sampling likelihood. URL: https://github.com/gersteinlab/ siglasso. R package version 1.1.
Li, S., Crawford, F.W., Gerstein, M.B., 2020. Using sigLASSO to optimize cancer mutation signatures jointly with sampling likelihood. Nature Communications 11, 3575.
Maura, F., Degasperi, A., Nadeu, F., Leongamornlert, D., Davies, H., Moore, L., Royo, R., Ziccheddu, B., Puente, X.S., Avet-Loiseau, H., Campbell, P.J., Nik-Zainal, S., Campo, E., Munshi, N., Bolli, N., 2019. A practical guide for mutational signature analysis in hematological malignancies. Nature Communications 10, 1–12.
Missa, O., Dytham, C., Morlon, H., 2016. Understanding how biodiversity unfolds through time under neutral theory. Philosophical Transactions of the Royal Society B: Biological Sciences 371, 20150226.
Nik-Zainal, S., Alexandrov, L.B., Wedge, D.C., Van Loo, P., Greenman, C.D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L.A., et al., 2012. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979–993.
Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L.B., Martin, S., Wedge, D.C., et al., 2016. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47–54.
Omichessan, H., Severi, G., Perduca, V., 2019. Computational tools to detect signatures of mutational processes in DNA from tumours: A review and empirical comparison of performance. PLoS ONE 14, e0221235.
Pandey, P., Arora, S., Rosen, G.L., 2022. MetaMutationalSigs: Comparison of mutational signature refitting results made easy. Bioinformatics 38, 2344–2347.
Riva, L., Pandiri, A.R., Li, Y.R., Droop, A., Hewinson, J., Quail, M.A., Iyer, V., Shepherd, R., Herbert, R.A., Campbell, P.J., et al., 2020. The mutational signature profile of known and suspected human carcinogens in mice. Nature Genetics 52, 1189–1197.
Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B.S., Swanton, C., 2016. DeconstructSigs: Delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biology 17, 1–11.
Rustad, E.H., Nadeu, F., Angelopoulos, N., Ziccheddu, B., Bolli, N., Puente, X.S., Campo, E., Landgren, O., Maura, F., 2021. mmsig: A fitting approach to accurately identify somatic mutational signatures in hematological malignancies. Communications Biology 4, 1–12.
Schumann, F., Blanc, E., Messerschmidt, C., Blankenstein, T., Busse, A., Beule, D., 2019. SigsPack, A package for cancer mutational signatures. BMC Bioinformatics 20, 1–9.
Van Hoeck, A., Tjoonk, N.H., van Boxtel, R., Cuppen, E., 2019. Portrait of a cancer: Mutational signature analyses for cancer diagnostics. BMC Cancer 19, 1–14.
Wang, S., Li, H., Song, M., Tao, Z., Wu, T., He, Z., Zhao, X., Wu, K., Liu, X.S., 2021. Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes. PLoS Genetics 17, e1009557.
Wu, Y., Chua, E.H.Z., Ng, A.W.T., Boot, A., Rozen, S.G., 2022. Accuracy of mutational signature software on correlated signatures. Scientific Reports 12, 1–12.
This paper is available on Arxiv under CC 4.0 license.